SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-062223
Filing Date
2017-11-21
Accepted
2017-11-21 21:01:54
Documents
2
Period of Report
2017-11-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3966
2 POA DOCUMENT poa.txt EX-24.4_753562 3018
  Complete submission text file 0001209191-17-062223.txt   8391
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Issuer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INSYS THERAPEUTICS, INC. 1333 SOUTH SPECTRUM BLVD, SUITE 100 CHANDLER AZ 85286
Business Address
Motahari Saeed (Reporting) CIK: 0001704399 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35902 | Film No.: 171218246